Webinar presenters Gwen Clarke, MD, FRCPC, Hematopathology and Transfusion Medicine, Island Health, Victoria British Columbia Canada, and Clinical Professor, Department of Laboratory Medicine Pathology, University of Alberta, and Nancy Robitaille, MD, FRCPC, Vice-President, Transfusion Medicine, Héma-Québec, Montreal Canada Hematology-Oncology, CHU Sainte-Justine, Montreal, Canada and Clinical Professor, Department of Pediatrics, Université de Montréal discuss how advancements in non-invasive prenatal testing (NIPT) for fetal RHD are transforming targeted antenatal prophylaxis with RhIG. However, successful implementation requires careful planning around:
• Test characteristics and quality indicators
• Blood sample transportation logistics
• Healthcare provider education
• Efficient reporting strategies
This on-demand webinar was originally broadcast on March 11, 2025.
What will you learn from this webinar?
• Discover the history of RhIG prophylaxis: Understand the origins and role of RhIG
in reducing the burden of hemolytic disease of the fetus and newborn (HDFN).
• Understand the benefits of fetal RHD genotyping: Learn how targeted RhIG
prophylaxis ensures care is delivered only to those who need it.
• Implement NIPT testing successfully: Gain insights into the critical steps for a
successful NIPT program, including potential quality indicators and best practices.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Devyser.